共 50 条
Clinical utility of circulating tumor DNA (ctDNA) next generation sequencing (NGS) to inform treatment decisions for patients (pts) with advanced solid tumors
被引:0
|作者:
Gomez Puerto, D. A.
[1
]
Rossi, A.
[2
]
Hernando Calvo, A.
[1
]
Ucha Hermida, J. M.
[1
]
Gomez, M.
[3
]
Matito, J.
[3
]
Vila-Casadesus, M.
[3
]
Morchon Araujo, D.
[4
]
Dienstmann, R.
[5
]
Galceran, J. C.
[1
]
Illescas, D. G.
[1
]
Macarulla Mercade, T.
[1
]
Garralda, E.
[1
]
Saura Manich, C.
[1
]
Elez Fernandez, M. E.
[1
]
Felip, E.
[1
]
Tabernero, J.
[1
]
Vivancos, A.
[3
]
机构:
[1] Vall dHebron Inst Oncol, Med Oncol Dept, Barcelona, Spain
[2] Azienda Osped Univ Integrata Verona, Med Oncol Dept, Verona, Italy
[3] VHIO Valle Hebron Inst Oncol, Genom Dept, Barcelona, Spain
[4] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain
[5] Vall dHebron Inst Oncol, Oncol Data Sci Dept, Barcelona, Spain
关键词:
D O I:
10.1016/j.annonc.2024.08.135
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
127P
引用
收藏
页码:S265 / S266
页数:2
相关论文